NVOS Novo Integrated Sciences Corp: Forvard narx/daromad multiplikatori

Ommaviy kompaniya Novo Integrated Sciences Inc (NVOS) logotipi

Biznesga kirish qat'iy HIPAA nazorati va litsenziyalash bilan cheklangan, biroq u IT integratsiyasi orqali himoyalangan. Forward P/S ko'rsatkichi baholash tendentsiyasini aks ettiradi, bunda 0.20 qiymati ushbu holatni ifodalaydi. Novo Integrated Sciences (NVOS) AQSh va Kanadada bemorlar diagnostikasi va davolashdan daromad oladi. Narxlarni belgilash imkoniyatining yetishmasligi, tibbiy xizmatlarga bo'lgan talabning yuqori elastikligi tufayli kompaniyani chegirmalar orqali raqobatlashishga majbur qilmoqda.

Novo Integrated Sciences, Inc. - NVOS Kapitalizatsiyaning kutilayotgan sotuvga nisbati (davr: 04.07.2022 - 16.11.2024)

Novo Integrated Sciences (NVOS) kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning dastlabki tahlili:Novo Integrated Sciences Inc NVOS
Novo Integrated Sciences Corp tomonidan chiqariladigan mahsulotlar

Ushbu ko'rsatkich Novo Integrated Sciences (NVOS) bozor qiymatining prognoz qilingan daromadga nisbatini aks ettiradi va kelajakdagi daromad oqimlari uchun to'langan premiumni baholash imkonini beradi. Kompaniyaning forward P/S ko'rsatkichini tahlil qilish orqali investor bozor kutganlarini mijozlar bazasining tez-tez uchraydigan tebranishlar xavfi va SEC tartibga soluvchi bosimi bilan solishtirishi mumkin, bu esa yirik bitimlar uchun moliyalashtirish beqarorligi sharoitida biznes baholovining uzoq muddatli barqarorligini belgilaydi.

Asosiy raqobatchilar

Forvard P/S multiplikatori HCA (HCA Healthcare, Inc.)|Narxning kutilayotgan daromadga nisbati THC (Tenet Healthcare)|FMS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati solventum.com|EHC: Forvard P/S multiplikatori|UHS - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|DVA (DaVita Corp) - Forvard P/S multiplikatori|RDNT: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori OPCH|SGRY (surgerypartners.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori PINC (Premier Inc)|National Vision - Narxning prognoz qilingan daromadga nisbati|PGNY - Narxning prognoz qilingan daromadga nisbati|ARDT - Forvard P/S multiplikatori|SEM: Forvard P/S multiplikatori|astranahealth.com (ASTH) - Forvard P/S multiplikatori|MD (mednax.com) - Forvard P/S multiplikatori|Forvard P/S multiplikatori usph.com|Forvard P/S multiplikatori PNTG|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Organogenesis Holdings|Forvard P/S multiplikatori NUTX (nutexhealth.com)|Auna SA (AUNA) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|SBC: Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Jeuveau EOLS|CYH (Community Health Systems Inc) - Forvard narx/daromad multiplikatori|SKIN: Narxning kutilayotgan daromadga nisbati|Forvard narx/daromad multiplikatori MDWD|BTMD: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati The Joint Corporation (JYNT)|Forvard P/S multiplikatori DocGo Inc (DCGO)|Sotuvga nisbatan forvard narx P3 Health Partners, Inc.|Kapitalizatsiyaning kutilayotgan sotuvga nisbati gaintherapeutics.com (GANX)|EUDA: Forvard narx/daromad multiplikatori|BMGL: Narxning prognoz qilingan daromadga nisbati|collplant.com (CLGN) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Cuprina Holdings|CCM (concordmedical.com) - Forvard P/S multiplikatori|Forvard P/S multiplikatori ASHS|Narxning prognoz qilingan daromadga nisbati MEDIROM (MRM)|ALBT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|DIH Holding US, Inc. - Forvard narx/daromad multiplikatori|Prognoz narxning daromadga nisbati Carmell Therapeutics Corporation|NewGenIvf Corp - Forvard P/S multiplikatori|ATI Physical Therapy, Inc. - Narxning kutilayotgan daromadga nisbati|CMAX: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati KDLY|Forvard narx/daromad multiplikatori MODV|Bozor kapitallashuvining kelajakdagi daromadga nisbati SunLink Health Systems SSY|Narxning prognoz qilingan daromadga nisbati IMAC Corp (BACK)